Cellosaurus cell line PD-1.6 (CVCL_B7F0)

PubMed=20587542; DOI=10.1093/intimm/dxq049
Ghiotto M., Gauthier L., Serriari N.-E., Pastor S., Truneh A., Nunes J.A., Olive D.
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.
Int. Immunol. 22:651-660(2010)

PubMed=20693422; DOI=10.4049/jimmunol.0902487
Serriari N.-E., Gondois-Rey F., Guillaume Y., Remmerswaal E.B.M., Pastor S., Messal N., Truneh A., Hirsch I., van Lier R.A.W., Olive D.
B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function.
J. Immunol. 185:3140-3148(2010)

Patent=US9637546
Olive D., Serriari N.-E., Nunes J.A., Ghiotto M.
PD-1 antibodies and PD-L1 antibodies and uses thereof.
Patent number US9637546, 02-May-2017

Patent=US9896507
Olive D., Gondois-Rey F., Serriari N.-E., Pastor S.
BTLA antibodies and uses thereof.
Patent number US9896507, 20-Feb-2018